Baoxin Pharmaceutical
Baoxin Pharmaceutical Co., Ltd., commonly referred to as Baoxin Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, primarily focusing on innovative drug formulations and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in Asia and beyond, Baoxin Pharma is dedicated to enhancing healthcare through its core offerings, which include a diverse range of prescription medications and over-the-counter products. The company is recognised for its commitment to research and development, ensuring that its products meet stringent quality standards and address critical health needs. Baoxin Pharmaceutical has positioned itself as a trusted name in the market, achieving notable milestones in product development and regulatory compliance, thereby solidifying its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Baoxin Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baoxin Pharmaceutical's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Baoxin Pharmaceutical's reported carbon emissions
Baoxin Pharmaceutical, headquartered in CN, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Baoxin Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Baoxin to establish clear emissions reduction goals and commitments to align with global climate standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Baoxin Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
